L
Laureano J. Rangel
Researcher at Mayo Clinic
Publications - 106
Citations - 4099
Laureano J. Rangel is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Prostatectomy & Prostate cancer. The author has an hindex of 31, co-authored 101 publications receiving 3542 citations. Previous affiliations of Laureano J. Rangel include University of Rochester.
Papers
More filters
Journal ArticleDOI
Imaging Classification of Autosomal Dominant Polycystic Kidney Disease: A Simple Model for Selecting Patients for Clinical Trials
Maria V. Irazabal,Laureano J. Rangel,Eric J. Bergstralh,Sara L. Osborn,Amber J. Harmon,Jamie L. Sundsbak,Kyongtae T. Bae,Arlene B. Chapman,Jared J. Grantham,Michal Mrug,Marie C. Hogan,Ziad M. El-Zoghby,Peter C. Harris,Bradley J. Erickson,Bernard F. King,Vicente E. Torres +15 more
TL;DR: A longitudinal mixed regression model to predict eGFR decline showed that log2HtTKV and age significantly interacted with time in typical patients, but not in atypical patients.
Journal ArticleDOI
Radical prostatectomy for prostatic adenocarcinoma: a matched comparison of open retropubic and robot-assisted techniques.
Amy E. Krambeck,David S. DiMarco,Laureano J. Rangel,Eric J. Bergstralh,Robert P. Myers,Michael L. Blute,Matthew T. Gettman +6 more
TL;DR: To assess the perioperative complications and early oncological results in a comparative study matching open radical retropubic (RRP) and robot‐assisted radical prostatectomy (RARP) groups.
Journal ArticleDOI
Long-Term Risk of Clinical Progression After Biochemical Recurrence Following Radical Prostatectomy: The Impact of Time from Surgery to Recurrence
Stephen A. Boorjian,R. Houston Thompson,Matthew K. Tollefson,Laureano J. Rangel,Eric J. Bergstralh,Michael L. Blute,R. Jeffrey Karnes +6 more
TL;DR: Only a minority of men experience systemic progression and death from PCa following RRP, and the decision to institute secondary therapies must balance the risk of disease progression with the cost and morbidity of treatment, independent of time from RRP to BCR.
Journal ArticleDOI
Long-Term Survival After Radical Prostatectomy Versus External Beam Radiotherapy for Patients with High-Risk Prostate Cancer
Stephen A. Boorjian,R. Jeffrey Karnes,Rosalia Viterbo,Laureano J. Rangel,Eric J. Bergstralh,Eric M. Horwitz,Michael L. Blute,Mark K. Buyyounouski +7 more
TL;DR: The long‐term survival of patients with high‐risk prostate cancer was compared after radical prostatectomy and after external beam radiation therapy (EBRT) with or without adjuvant androgen‐deprivation therapy (ADT).
Journal ArticleDOI
Mayo Clinic Validation of the D’Amico Risk Group Classification for Predicting Survival Following Radical Prostatectomy
Stephen A. Boorjian,R. Jeffrey Karnes,Laureano J. Rangel,Eric J. Bergstralh,Michael L. Blute +4 more
TL;DR: The ability of the risk group stratification to predict disease progression and patient survival following radical prostatectomy was validated and additional prognostic information from surgical staging may assist in individualized postoperative management, particularly for patients at high risk.